Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Total 13F shares
-
38,480,445
-
Share change
-
-4,843,946
-
Total reported value
-
$259,361,000
-
Put/Call ratio
-
99%
-
Price per share
-
$6.74
-
Number of holders
-
61
-
Value change
-
-$31,879,222
-
Number of buys
-
33
-
Number of sells
-
37
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q2 2021
As of 30 Jun 2021 ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) had 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,480,445 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, GOLDMAN SACHS GROUP INC, JENNISON ASSOCIATES LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Opaleye Management Inc., DAFNA Capital Management LLC, and FIL Ltd.
This table shows 61 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.